Indole derivatives
US5216001A · kind A · utility
14Cited by
5References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 27, 1991 |
| Grant date | Jun 1, 1993 |
| Priority date | — |
| Expiry date | Jun 27, 2011 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Specific 6-substituted or 2-alkyl substituted indole or 2,3-dihydroindole compounds are provided, having long lasting serotonin activity with specific binding to 5-HT.sub.2 receptors of the central nervous system. These compounds are suitable for therapeutic treatment of CNS disorders, such as anxiety, depression, sleep disturbances, migraine, negative symptoms of schizophrenia, and Parkinson's disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.